<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02671136</url>
  </required_header>
  <id_info>
    <org_study_id>5150307</org_study_id>
    <nct_id>NCT02671136</nct_id>
  </id_info>
  <brief_title>Hyperbaric Oxygen Therapy as Adjunctive Therapy to Scaling and Root-planing in the Management of Periodontitis in Patients With Type 2 Diabetes</brief_title>
  <official_title>Hyperbaric Oxygen Therapy as Adjunctive Therapy to Scaling and Root-planing in the Management of Periodontitis in Patients With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes and Periodontitis are both prevalent diseases affecting millions of Americans.
      Periodontitis is prevalent among Diabetics. Furthermore, Periodontitis and associated
      inflammation can increase insulin resistance in Diabetics and worsens the condition.
      Hyperbaric Oxygen Therapy (HBOT) has the potential to improve periodontal treatment outcome
      in poorly controlled diabetics. The study will compare periodontal treatment (SRP) outcome
      between 2 main diabetic type 2 patient groups receiving medical care treatment: either
      Conventional Wound Therapies (CWC) with or without adjunctive Hyperbaric Oxygen Therapy at
      LLU Health.

      24 poorly controlled diabetic mellitus (DM) type 2 subjects (HbA1c =&gt;7%) with Periodontitis
      will be assigned into the study arms HBO therapy and Non HBO therapy, based on their medical
      needs.

      For all subjects demographic data (age, gender, ethnicity, smoking history, alcohol use
      history, BMI, current medication list) and oral health habits will be obtained. Blood samples
      for HbA1c determinations, clinical periodontal measurements (plaque index, probing
      measurements including pocket depth, attachment levels, gingival index and
      bleeding-on-probing) and subgingival microbial samples will be obtained at baseline and end
      of the study. Subgingival microbial samples will be collected from three randomly selected
      sites and analyzed for detection of about 300 of the most prevalent oral bacterial species.
      Differences in periodontal clinical outcomes and bacterial profiles will be identified
      utilizing ANCOVA (Analysis of Covariance).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of subjects
  </why_stopped>
  <start_date type="Actual">August 18, 2016</start_date>
  <completion_date type="Actual">March 31, 2017</completion_date>
  <primary_completion_date type="Actual">March 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Counts of Each Subgingival Bacterial Species</measure>
    <time_frame>12 weeks</time_frame>
    <description>Subgingival microbial samples will be obtained at baseline and end of the study. Subgingival microbial samples will be collected from three randomly selected sites with probing depth =&gt;5mm. Collected microbial samples will be processed for HOMINGS analysis (The Human Oral Microbe Identification Microarray). Counts and proportions of each bacterial species will be determined for each subject and then averaged across subjects in the two groups. Differences in bacterial profiles will be analyzed using the repeated measures ANCOVA (Analysis of Covariance) procedure for paired observations.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Diabetes</condition>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>CWC with HBO</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional Wound Therapies (CWC) with adjunctive Hyperbaric Oxygen Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CWC without HBO</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional Wound Therapies (CWC) without adjunctive Hyperbaric Oxygen Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyperbaric Oxygen therapy</intervention_name>
    <arm_group_label>CWC with HBO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional Wound Therapies</intervention_name>
    <arm_group_label>CWC with HBO</arm_group_label>
    <arm_group_label>CWC without HBO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes type 2 (HbA1c =&gt;7%)

          -  Generalized moderate to severe chronic periodontitis.

          -  Minimum of 10 permanent teeth

          -  Registered LLU patients

        Exclusion Criteria:

          -  Well controlled Diabetes type 2

          -  Other systematic conditions with known associations to periodontitis

          -  Intra-oral conditions which may interfere with the accuracy of periodontal probing

          -  BMI greater than 45%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Khocht, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92346</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>October 6, 2015</study_first_submitted>
  <study_first_submitted_qc>January 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2016</study_first_posted>
  <results_first_submitted>August 22, 2018</results_first_submitted>
  <results_first_submitted_qc>February 15, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">March 13, 2019</results_first_posted>
  <last_update_submitted>February 15, 2019</last_update_submitted>
  <last_update_submitted_qc>February 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 30, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/36/NCT02671136/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>CWC With HBO</title>
          <description>Conventional Wound Therapies (CWC) with adjunctive Hyperbaric Oxygen Therapy
Hyperbaric Oxygen therapy
Conventional Wound Therapies</description>
        </group>
        <group group_id="P2">
          <title>CWC Without HBO</title>
          <description>Conventional Wound Therapies (CWC) without adjunctive Hyperbaric Oxygen Therapy
Conventional Wound Therapies</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This project was terminated early due to not enough subjects recruited.</population>
      <group_list>
        <group group_id="B1">
          <title>CWC With HBO</title>
          <description>Conventional Wound Therapies (CWC) with adjunctive Hyperbaric Oxygen Therapy
Hyperbaric Oxygen therapy
Conventional Wound Therapies</description>
        </group>
        <group group_id="B2">
          <title>CWC Without HBO</title>
          <description>Conventional Wound Therapies (CWC) without adjunctive Hyperbaric Oxygen Therapy
Conventional Wound Therapies</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Counts of Each Subgingival Bacterial Species</title>
        <description>Subgingival microbial samples will be obtained at baseline and end of the study. Subgingival microbial samples will be collected from three randomly selected sites with probing depth =&gt;5mm. Collected microbial samples will be processed for HOMINGS analysis (The Human Oral Microbe Identification Microarray). Counts and proportions of each bacterial species will be determined for each subject and then averaged across subjects in the two groups. Differences in bacterial profiles will be analyzed using the repeated measures ANCOVA (Analysis of Covariance) procedure for paired observations.</description>
        <time_frame>12 weeks</time_frame>
        <population>No analysis conducted due to not enough subjects recruited and study terminated early.</population>
        <group_list>
          <group group_id="O1">
            <title>CWC With HBO</title>
            <description>Conventional Wound Therapies (CWC) with adjunctive Hyperbaric Oxygen Therapy
Hyperbaric Oxygen therapy
Conventional Wound Therapies</description>
          </group>
          <group group_id="O2">
            <title>CWC Without HBO</title>
            <description>Conventional Wound Therapies (CWC) without adjunctive Hyperbaric Oxygen Therapy
Conventional Wound Therapies</description>
          </group>
        </group_list>
        <measure>
          <title>Counts of Each Subgingival Bacterial Species</title>
          <description>Subgingival microbial samples will be obtained at baseline and end of the study. Subgingival microbial samples will be collected from three randomly selected sites with probing depth =&gt;5mm. Collected microbial samples will be processed for HOMINGS analysis (The Human Oral Microbe Identification Microarray). Counts and proportions of each bacterial species will be determined for each subject and then averaged across subjects in the two groups. Differences in bacterial profiles will be analyzed using the repeated measures ANCOVA (Analysis of Covariance) procedure for paired observations.</description>
          <population>No analysis conducted due to not enough subjects recruited and study terminated early.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>No adverse event data collected. Study terminated early due to not enough subjects enrolled.</time_frame>
      <desc>No adverse event data collected. Study terminated early due to not enough subjects enrolled.</desc>
      <group_list>
        <group group_id="E1">
          <title>CWC With HBO</title>
          <description>Conventional Wound Therapies (CWC) with adjunctive Hyperbaric Oxygen Therapy
Hyperbaric Oxygen therapy
Conventional Wound Therapies</description>
        </group>
        <group group_id="E2">
          <title>CWC Without HBO</title>
          <description>Conventional Wound Therapies (CWC) without adjunctive Hyperbaric Oxygen Therapy
Conventional Wound Therapies</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ahmed Khocht</name_or_title>
      <organization>Loma Linda University Health</organization>
      <phone>909 558 4000</phone>
      <email>akhocht@llu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

